Joint & Bone Health

A recent study found that a proprietary aqueous extract of cucumber called Q-Actin, helped improve symptoms of moderate osteoarthritis in a dose-dependent manner.

Lehvoss will distribute three of Unigen’s branded ingredients in Europe: Univestin for joint support, Attenutin for respiratory health support, and Anivestin for joint support and oral health in companion animals.

One of Lonza’s introductions at the Expo West show will be technology to coat capsules with naturally derived flavors and aromas.

When will collagen sales slow down? Not this year, sources say.

Vitamins and minerals, particularly multivitamin and multimineral formulations, are growing as consumers seek cost-effective ways to personalize their nutrition.

Nutritional Outlook’s Editorial Advisory Board shares its predictions and tips for success in 2023.

A multivitamin is still a good foundation, but there’s considerable white space in the market for trendy, condition-specific kids formulas.

Newer bone health ingredients are building on strong research.

Kerry’s Niamh Hunt discusses the role of consumer demographics in the functional food and beverage markets.

Long-chain menaquinones like vitamin K2 MK-7 can present stability challenges, the company says.

Results showed that in a cumulative responder analysis, subjects taking 500 mg of Rhuleave-K saw a 62% improvement, compared to placebo.

The vitamin K2 MK-7 ingredient has been studied in 10 human clinical trials, including studies on bioavailability, bone health, and heart health.

The company, which specializes in producing ingredients using precision fermentation and enzymatic bioconversion, says its process can produce any long-chain menaquinone, including 6, 7, 8, and 9.

The ingredient combines inulin, the company’s newly launched OptiXOS xylo-oligosaccharide prebiotic fiber, and magnesium.

Exploring the opportunities and regulatory challenges of hemp-derived cannabinoids in pet supplements.

The company says K2Vital MCT Organic is the “first USDA organic–certified, all-trans, all-bioactive vitamin K2 MK-7 for oil-based health applications to the U.S. market.”

The ingredient is delivered in the company’s Matrix technology that protects particles of MK-7 without coating, additives, or additional ingredients.

The companies will work jointly on the development and distribution of a clinically-backed collagen product that is manufactured from premium ling maw supplied by NZCS.

Called bio+Quercitrin, the ingredient is said to be up to six times more bioavailable than standard quercetin.

Bioactive collagen peptides Fortigel from Gelita has been authorized by the National Health Agency (Anvisa) in Brazil to carry the claim “may contribute to the maintenance of joint health.”

Vedic Lifesciences, a contract research organization based, has completed a randomized, controlled dose response study for Interpath Pty Ltd. on its patented ingredient called Epiitalis.

An influx of next-generation ingredients and a growing consumer need are driving joint health supplements to new heights.

As consumers get active post-pandemic, they’ll find a wider range of sports supplements ready to cater to their every need.

The CRN Foundation has published a new economic report which analyzes the potential healthcare cost savings that could be realized if at-risk populations used specific dietary supplements as a form of preventative healthcare.

Kappa Bioscience (Oslo, Norway) has appointed John E. Repine, MD as the newest member of its “Blue Ribbon” Scientific and Medical Advisory Board.